1887

Journal of General Virology header logo

Volume 69, Issue 8

Antibody Responses to Murine Cytomegalovirus in Genetically Resistant and Susceptible Strains of Mice Free

Abstract

Summary

The role of antibodies as mediators of genetically determined resistance to murine cytomegalovirus (MCMV) in mice has not been elucidated. The ability of mice with different MCMV resistance phenotypes to produce an antibody response to MCMV was investigated in order to assess whether the host genotypes that control resistance also influence antibody production. Antibodies to MCMV in the sera of resistant (BALB.K, CBA/CaH, B10.BR) and susceptible [BALB/c, BALB.B, C57BL/10ScSn (B10), B10.D2, B10.A, A/J] mice were determined by ELISA and/or a complement-requiring neutralization assay. IgM antibodies were produced by all strains of mice as early as 3 to 5 days post-infection (p.i.) with maximum titres observed after 10 days p.i. for some strains, whilst IgG antibodies were produced by 5 to 7 days p.i. with maximum titres at 20 days p.i. IgA antibodies were not detected in the sera of MCMV-infected mice. Virulent MCMV induced higher antibody titres than either attenuated or u.v.-inactivated forms of the virus. Although high doses of virulent virus delayed the early production of IgM antibody they did not adversely affect the kinetics of IgG antibody production. High titres of neutralizing antibodies were detected as early as day 3 post-inoculation of virulent virus; when attenuated virus was used in the neutralization assay, this was found to be more easily neutralized than salivary gland-derived virus. Interestingly, although guinea-pig complement greatly enhanced antibody-mediated neutralization of MCMV, mouse complement was also effective at enhancing neutralization. Although genetically determined resistance to MCMV is an early event with the resistant phenotype being demonstrable during the first few days of the infection, there was no evidence that antibodies were responsible for this resistance since neither antibody titres nor the time of first appearance of antibody correlated with resistance status. However, these results do not exclude a more general role for antibody in limiting MCMV infection, especially in immunity to re-infection since passively transferred antibodies from resistant or susceptible mouse strains lowered virus titres in MCMV-infected animals.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antibody response , MCMV and resistance
© Society for General Microbiology 1988
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-69-8-1987
1988-08-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/69/8/JV0690081987.html?itemId=/content/journal/jgv/10.1099/0022-1317-69-8-1987&mimeType=html&fmt=ahah

References

  1. ALLAN J. E., SHELLAM G. R. 1984; Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Archives of Virology 81:139–150
     [Google Scholar]
  2. ALLAN J. E., SHELLAM G. R. 1985; Characterization of interferon induction in mice of resistant and susceptible strains during murine cytomegalovirus infection. Journal of General Virology 66:1105–1112
     [Google Scholar]
  3. ANDERSON C. A., MURPHY J. C., FOX J. G. 1986; Surveillance of mice for antibodies to murine cytomegalovirus. Journal of Clinical Microbiology 23:1152–1154
     [Google Scholar]
  4. ARAULLO-CRUZ T., HO M., ARMSTRONG J. 1978; Protective effect of early serum from mice after murine cytomegalovirus infection. Infection and Immunity 21:840–842
     [Google Scholar]
  5. BANCROFT G. J., SHELLAM G. R., CHALMER J. E. 1981; Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. Journal of Immunology 126:988–994
     [Google Scholar]
  6. BERRY D. M., ALMEIDA J. D. 1968; The morphological and biological effects of various antisera on avian infectious bronchitis virus. Journal of General Virology 3:97–102
     [Google Scholar]
  7. CHALMER J. E., MACKENZIE J. S., STANLEY N. F. 1977; Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. Journal of General Virology 37:107–114
     [Google Scholar]
  8. CHONG K. T., GOULD J. J., MIMS C. A. 1981; Neutralization of different strains of murine cytomegalovirus (MCMV) - effect of in vitro passage. Archives of Virology 69:95–104
     [Google Scholar]
  9. CLASSEN D. C, MORNINGSTAR J. M., SHANLEY J. D. 1987; Detection of antibody to murine cytomegalovirus by enzyme-linked immunosorbent and indirect immunofluorescence assays. Journal of Clinical Microbiology 25:600–604
     [Google Scholar]
  10. EIZURU Y., MINAMISHIMA Y. 1979; Co-variation of pathogenicity and antigenicity in murine cytomegalovirus. Microbiology and Immunology 23:559–564
     [Google Scholar]
  11. GRUNDY (CHALMER) J. E., MELIEF C. J. M. 1982; Effect of Nu/Nu gene on genetically determined resistance to murine cytomegalovirus. Journal of General Virology 61:133–136
     [Google Scholar]
  12. GRUNDY (CHALMER) J. E., MACKENZIE J. S., STANLEY N. F. 1981; Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infection and Immunity 32:277–286
     [Google Scholar]
  13. GRUNDY (CHALMER) J. E., TRAPMAN J., ALLAN J. E., SHELLAM G. R., MELIEF C J. M. 1982; Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. Infection and Immunity 37:143–150
     [Google Scholar]
  14. HANSHAW J. 1968 Cytomegalovirus. Virology Monographs 31–23 Edited by Gard S., Hallauer C., Meyer K. F. Wein & New York: Springer-Verlag;
     [Google Scholar]
  15. HARNETT G. B., SHELLAM G. R. 1982; Variation in murine cytomegalovirus replication in fibroblasts from different mouse strains in vitro: correlation with in vivo resistance. Journal of General Virology 62:39–47
     [Google Scholar]
  16. HARNETT G. B., SHELLAM G. R. 1985 The role of interferon in the expression of genetically determined resistance to murine cytomegalovirus (MCMV). Progress in Leukocyte Biology. Genetic Control of Host Resistance to Infection and Malignancy 3181–186 Edited by Skamene E. New York: Alan R. Liss;
     [Google Scholar]
  17. HEIDI K., SCHWICH H. G. 1978 Salt fractionation of immunoglobulins. Handbook of Experimental Immunology, 3rd edn.7.01–7.11 Edited by Weir D. M. Oxford: Blackwell Scientific Publications;
     [Google Scholar]
  18. INADA T., MIMS C. A. 1985; Association of virulence of murine cytomegalovirus with macrophage susceptibility and with virion-bound non-neutralizing antibody. Journal of General Virology 66:879–882
     [Google Scholar]
  19. INADA T., CHONG K. T., MIMS C. A. 1985; Enhancing antibodies, macrophages and virulence in mouse cytomegalovirus infection. Journal of General Virology 66:871–878
     [Google Scholar]
  20. KIM K., CARP R. 1973; Influence of complement on the neutralization of murine cytomegalovirus by rabbit antibody. Journal of Virology 12:1620–1621
     [Google Scholar]
  21. LAWSON C. M., GRUNDY J. E., SHELLAM G. R. 1987; Delayed-type hypersensitivity responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. Journal of General Virology 68:2379–2388
     [Google Scholar]
  22. MASUHO Y., MATSUMOTO Y-I., SUGANO T., FUIINAGA S., MINAMISHIMA Y. 1987; Human monoclonal antibodies neutralizing human cytomegalovirus. Journal of General Virology 68:1457–1461
     [Google Scholar]
  23. MEDEARIS D. JR 1964; Mouse cytomegalovirus infection. II. Observations during prolonged infections. American Journal of Hygiene 80:103–112
     [Google Scholar]
  24. MEDEARIS D. JR, PROKAY S. 1978; Effect of immunization of mothers on cytomegalovirus infection in suckling mice. Proceedings of the Society for Experimental Biology and Medicine 157:523–527
     [Google Scholar]
  25. NOTKINS A. L. 1974; Immune mechanisms by which the spread of viral infections is stopped. Cellular Immunology II:478–483
     [Google Scholar]
  26. OLDSTONE M. B. A. 1975; Virus neutralization and virus-induced immune complex disease. Progress in Medical Virology 19:84–119
     [Google Scholar]
  27. OLDSTONE M. B. A., COOPER N. R., LARSON D. L. 1974; Formation and biologic role of polyoma virus-antibody complexes. A critical role for complement. Journal of Experimental Medicine 140:549–565
     [Google Scholar]
  28. OROSZLAN S., GILDEN R. V. 1970; Immune virolysis: effect of antibody and complement on C-type RNA virus. Science 168:1478–1480
     [Google Scholar]
  29. OSBORN J. E., WALKER D. L. 1970; Virulence and attenuation of murine cytomegalovirus. Infection and Immunity 3:228–236
     [Google Scholar]
  30. PRICE P., WINTER J. G., NIKOLETTI S., HUDSON J., SHELLAM G. R. 1987; Functional changes in murine macrophages infected with cytomegalovirus relate to H-2 determined sensitivity to infection. Journal of Virology 61:3602–3606
     [Google Scholar]
  31. QUINNAN G. JR, MANISCHEWITZ J. F. 1987; Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication. Journal of Virology 61:1875–1881
     [Google Scholar]
  32. ROSENBERG G. L., NOTKINS A. L. 1974; Induction of cellular immunity to herpes simplex virus: relationship to the humoral immune response. Journal of Immunology 112:1019–1025
     [Google Scholar]
  33. SCHLUEDERBERG A., AJELLO C, EVANS B. 1976; Fate of rubella genome ribonucleic acid after immune and nonimmune virolysis in the presence of ribonuclease. Infection and Immunity 14:1097–1102
     [Google Scholar]
  34. SELGRADE M. K., AHMED A., SELL K. W., GERSHWIN E. M., STEINBERG A. D. 1976; Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens. Journal of Immunology 116:1459–1465
     [Google Scholar]
  35. SHANLEY J., JORDAN M., STEVENS J. 1981; Modification by adoptive humoral immunity of murine cytomegalovirus infection. Journal of Infectious Diseases 143:231–237
     [Google Scholar]
  36. SHELLAM G. R., ALLAN J. E., PAPADLMITRIOU J. M. A, BANCROFT G. J. 1981; Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proceedings of the National Academy of Sciences, U.S.A 78:5104–5108
     [Google Scholar]
  37. SHELLAM G. R., GRUNDY J. E., HARNETT G. B., ALLAN J. E. 1983 Natural resistance against cytomegalovirus and other viruses of mice. Progress in Immunology 51209–1217 Edited by Yamamura Y., Tada T. Tokyo, New York & London: Academic Press;
     [Google Scholar]
  38. SHELLAM G. R., FLEXMAN J. P., FARRELL H. E., PAPADLMITRIOU J. M. 1985; The genetic background modulates the effect of the beige gene on susceptibility to cytomegalovirus infection in mice. Scandinavian Journal of Immunology 22:147–155
     [Google Scholar]
  39. YOSHINO K., TANIGUCHI S. 1965; Studies on the neutralization of herpes simplex virus. I. Appearance of neutralizing antibodies having different grades of complement requirement. Virology 26:44–53
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-69-8-1987
Loading
Antibody Responses to Murine Cytomegalovirus in Genetically Resistant and Susceptible Strains of Mice
J. Gen. Virol. 69, 1987 (1988); https://doi.org/10.1099/0022-1317-69-8-1987
/content/journal/jgv/10.1099/0022-1317-69-8-1987
/content/journal/jgv/10.1099/0022-1317-69-8-1987
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error